Topical ketoprofen patch

Area of Science:

• Pharmacology
• Pain Management
• Dermatology

Background:

• Oral nonsteroidal anti-inflammatory drugs (NSAIDs) effectively treat pain but carry risks of systemic adverse effects, especially gastrointestinal issues.
• Topical NSAIDs offer a localized treatment approach to minimize systemic exposure.
• A novel topical ketoprofen patch formulation has been developed for enhanced drug delivery.

Purpose of the Study:

• To review the pharmacokinetics, efficacy, and tolerability of a new topical ketoprofen patch.
• To evaluate the safety and effectiveness of the ketoprofen patch compared to placebo for pain relief.

Main Methods:

• Pharmacokinetic analysis of ketoprofen absorption and bioavailability from the topical patch.
• Phase III clinical trials assessing pain reduction in patients with non-articular rheumatism and traumatic soft tissue injuries.
• Adverse event monitoring, focusing on systemic and local reactions, including gastrointestinal effects.

Main Results:

• The topical ketoprofen patch achieves therapeutic tissue concentrations with significantly lower systemic bioavailability (<10% of oral) compared to oral ketoprofen.
• Phase III trials demonstrated the patch's superior efficacy over placebo in reducing both spontaneous and activity-related pain within 7 days.
• The ketoprofen patch was well-tolerated, with adverse events primarily localized skin reactions similar to placebo, and a low incidence of gastrointestinal issues.

Conclusions:

• The topical ketoprofen patch is an effective and safe option for managing local pain and inflammation.
• This formulation provides targeted drug delivery, minimizing systemic risks associated with oral NSAIDs.
• The favorable tolerability profile, with low gastrointestinal adverse event rates, supports its use as a localized pain management strategy.